Blood thinners may boost survival for prostate cancer patients

February 21, 2013 by Denise Mann, Healthday Reporter
Blood thinners may boost survival for prostate cancer patients: study
But it's too early to recommend anticoagulants for this purpose.

(HealthDay)—Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests.

patients who were also taking a blood thinner, usually to stave off a blood clot, had a 39 percent increase in overall survival over men who were not taking these drugs, report researchers from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.

But the study authors and outside experts caution that can't be prescribed routinely to , as they confer risks including bleeding, although men who need an anticoagulant might also find it beneficial in terms of prostate cancer. The findings were presented this month by Caroline Pratz and colleagues at an American Society of Clinical Oncology (ASCO) conference in Orlando, Fla.

The U.S. estimates that this year almost 239,000 new cases of prostate cancer will be diagnosed in the United States, and nearly 30,000 men will die from the disease.

The new study included almost 250 men with advanced or spreading prostate cancer who were receiving chemotherapy. Of these, 11.7 percent were also taking a blood thinner to prevent potentially fatal that could detach and reach their lungs, known as a . The men taking blood thinners— and warfarin were included—survived for about 21 months, compared to slightly more than 17 months for men who were not taking blood thinners.

The finding was surprising, because the researchers thought venous thromboembolism—clots deep in the leg veins—would negatively affect overall survival.

But how or even if the blood-thinning medications could confer a survival edge is unknown. The study only shows an association, it does not show that it's the blood thinners themselves that made the difference, said Dr. Cy Stein, an oncologist at the City of Hope Medical Center in Duarte, Calif., who was not involved with the study.

"Maybe men who develop blood clots have something else that affects how they respond to chemotherapy. We just don't know," Stein said.

Another expert said this is not the first time that blood thinners, including aspirin (which was not included in the new study), have been linked to improved survival for men with prostate cancer.

"Most of the data comes out of studies where oncology patients are being treated with blood thinners to prevent blood clots and incidentally there was some improvement in survival," said Dr. Manish Vira, director of the fellowship program in urologic oncology at North Shore-LIJ's Arthur Smith Institute for Urology in Lake Success, N.Y.

The new findings are "thought-provoking, but we should not just go ahead and treat everyone with cancer with blood thinners based on this study," he said.

Further research is needed, agreed Dr. Eric Singer, a urologic oncologist at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School in New Brunswick, N.J. "There is evidence from a number of studies suggesting that blood thinners might interact in some different ways with cancer and its treatment," Singer said.

"The guys who were getting [blood thinners] did better and something could be going on there, but keep in mind that being on a blood thinner comes with a risk of bleeding and stroke and should not be used lightly," Singer added.

More work is needed to confirm the results, and then to determine the ideal anticoagulant as well as the dose, timing and related risks, the study authors said.

Explore further: Preventive use of blood thinners by cancer patients could save lives, cut costs

More information: The U.S. National Cancer Institute has more on prostate cancer.

Related Stories

Preventive use of blood thinners by cancer patients could save lives, cut costs

December 13, 2011
(Medical Xpress) -- Preventive use of blood thinners, or anticoagulants, in  people receiving outpatient treatment for cancer could prevent the development of blood clots and improve their quality of life, according ...

Blood thinner may protect cancer patients from potentially fatal clots

June 7, 2011
A new type of anti-clotting drug called semuloparin has been found to reduce the development of potentially fatal blood clots in the veins that often occur in cancer patients, doctors at Duke Cancer Institute and elsewhere ...

ASCO: anticoagulant use predicts metastatic prostate CA survival

February 19, 2013
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to research presented ...

New blood thinner beats older drug for vein clots

February 20, 2013
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, researchers report.

Study discovers gene signature that predicts prostate cancer survival

October 10, 2012
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October ...

Recommended for you

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Using artificial intelligence to improve early breast cancer detection

October 17, 2017
Every year 40,000 women die from breast cancer in the U.S. alone. When cancers are found early, they can often be cured. Mammograms are the best test available, but they're still imperfect and often result in false positive ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.